Multiple XRP (XRP) indicators have hinted at a potential 25% relief rally in the coming weeks.

Key takeaways:

• XRP price looks poised to print a rare death cross with a rebound setup toward $1.40.
• XRP may also be forming a broader bottom, eyeing a larger rally toward $8 in the coming months.

XRP’s mean-reversion setup may send price toward $1.40

As of Monday, XRP’s 20-week exponential moving average (20-week EMA, green) near $1.40 was on the verge of crossing below its 200-week EMA (blue) near $1.39.

A confirmed weekly close below the longer-term average would mark a rare death cross between the two trend gauges.

XRP/USD weekly chart. Source: TradingView

In the past, XRP’s previous 20-week/200-week EMA crosses were followed by relief rebounds back toward the 200-week EMA. That includes a roughly 20% recovery in 2019 and a larger 82.7% rebound in 2022.

A similar mean-reversion move this time would put the $1.39–$1.40 area in focus, implying roughly 23%–25% upside by July from XRP’s current price near $1.13.

XRP’s weekly relative strength index, or RSI, was also hovering just above the oversold threshold of 30 on Monday.

The RSI measures whether an asset is becoming overheated or overly sold. Readings near 30 typically suggest that sellers may be running out of momentum, raising the odds of a short-term rebound even if the broader trend remains weak.

XRP shorts create $1.40 price magnet

Binance XRP/USDT liquidation heatmap data further supports the relief-rally setup.

The chart shows a heavier concentration of short liquidation liquidity above the current price than long liquidation liquidity below it. The largest upside cluster, of around $236.5 million, appears around the $1.37–$1.40 zone, according to CoinGlass data.

XRP/USDT one-month liquidation heatmap. Source: CoinGlass

Liquidation heatmaps often highlight where prices may move to flush out crowded leveraged positions.

Short sellers positioned above the spot price could be forced to buy back their exposure if XRP starts rebounding from the current $1.13 price levels, adding fuel to a move toward the $1.39–$1.40 area.

XRP may rebound toward $8: Analyst

A separate long-term chart from analyst Cryptollica suggests that XRP’s next rebound could be part of a broader bottoming setup.

The chart shows XRP’s 10-day RSI hovering near the low-30s, close to the level that has historically appeared around major accumulation phases.

XRP/USD 10-day chart. Source: TradingView

“In 13 years, XRP has only been this washed out 3 times,” Cryptollica said in a Sunday post, adding:

“The first 2 times, the crowd laughed, ignored it, and only understood the setup after price had already left.”

Cryptollica’s chart also shows XRP trading above the lower boundary of a giant ascending channel, a long-term support line that has connected multiple macro lows since 2017.

Related: XRP whale wallet withdrawals top 720M as risk-adjusted return data points to opportunity

That trend line currently sits near $0.75, meaning XRP could still see one more downside sweep before a larger recovery begins. In previous cycles, tests of this support area preceded major upside expansions.

XRP could first retest the channel support before entering a broader bull-market phase, with the channel’s upper boundary putting a long-term target near $8 in focus if the pattern plays out again.

Key Highlights

• ORCL shares declined 4.61% even as Baystate Health expanded its technology partnership.

• Baystate Health will deploy Oracle Health solutions across its Massachusetts care facilities.

• The partnership includes Oracle Health EHR and Clinical AI Agent technology.

• A unified digital platform will connect patients, providers, and administrative systems.

• The expanded agreement will facilitate Baystate’s upcoming Mercy Medical Center affiliation.

Shares of Oracle Corporation (ORCL) declined 4.61% to close at $175.79 on Wednesday, even after announcing a significant healthcare technology partnership with Baystate Health. The stock retreated from an early session peak near $184 before attempting a modest recovery late in trading. Baystate Health revealed intentions to broaden its use of Oracle technology throughout its extensive care delivery network.

Oracle Corporation, ORCL

ORCL Shares Experience Session-Long Pressure

Oracle stock encountered persistent selling pressure throughout Wednesday’s trading session, finishing $8.48 lower than the prior day’s close. The shares began the day near $182 but couldn’t sustain early gains. Downward momentum intensified during the afternoon, pushing the stock toward $175.

A brief rally materialized in the final trading hour, yet proved insufficient to reverse the day’s losses. Oracle concluded the session close to its intraday low despite announcing the expanded Baystate Health agreement. The price action indicated that positive healthcare news couldn’t offset broader selling interest in the stock.

Oracle delivers cloud-based software solutions, database management systems, infrastructure services, and healthcare technologies to a global customer base. The technology giant entered the healthcare sector significantly after completing its approximately $28.3 billion acquisition of Cerner in 2022. Oracle now integrates electronic health records, cloud computing infrastructure, data analytics, and workflow automation throughout its healthcare division.

Baystate Health Broadens Oracle Health Deployment

Baystate Health announced plans to significantly expand its Oracle Health technology implementation across hospitals, ambulatory clinics, and insurance operations. The Massachusetts-based integrated health system provides care to more than 800,000 individuals through five hospital facilities and over 80 outpatient medical practices. The organization also manages Health New England insurance, home healthcare services, and hospice care programs.

The healthcare system will implement Oracle Health EHR to centralize clinical documentation and enhance patient information accessibility. Additionally, Baystate will integrate Oracle Health Clinical AI Agent to automate documentation workflows and minimize administrative burden. The organization anticipates these systems will facilitate better data exchange among clinicians, hospital systems, outpatient practices, and insurance plan administrators.

Baystate will implement Oracle Health Patient Accounting to modernize billing operations and enhance financial process management. The solution leverages automation technology to streamline operational tasks and deliver improved visibility into financial performance across the health system. Oracle Health AI Data Platform will integrate clinical, financial, and insurance information within a unified data infrastructure.

Integrated System Facilitates Care Network Growth

Baystate Health will also launch Oracle Health Patient Portal as its centralized digital engagement platform. The portal will enable patients to access medical records, schedule appointments, and interact directly with healthcare providers. Patients will gain improved visibility into treatment protocols and additional healthcare services.

The broadened technology agreement will facilitate Baystate’s anticipated affiliation with Mercy Medical Center located in Springfield, Massachusetts. Baystate projects the corporate merger will become effective November 1, 2026, pending regulatory clearance. A consolidated Oracle platform will integrate Mercy Medical Center into Baystate’s broader healthcare delivery network.

Baystate employs approximately 13,000 healthcare professionals across its hospital facilities, medical practices, insurance division, and community health programs. The organization anticipates Oracle systems will decrease administrative burden for staff members and accelerate training processes in outpatient environments. Nevertheless, Oracle shares concluded Wednesday’s session with substantial losses despite the expanded healthcare technology collaboration.

Strategy, the best-known corporate Bitcoin holder, has continued adding to its Treasury and bolstering its liquidity at the same time. According to a Monday 8‑K filing with the U.S. Securities and Exchange Commission, the company purchased an additional 520 Bitcoin for $34.9 million between June 15 and Sunday, bringing its total holdings to 847,363 BTC.

The same filing also points to a larger funding goal beyond the Bitcoin purchase: Strategy said it added $300 million to its U.S. dollar reserve, bringing that buffer to $1.4 billion. Investors have been watching both moves closely because Strategy’s capital-raising approach—especially its use of equity sales—has become a reference point for other Bitcoin treasury companies.

Key takeaways

• Strategy bought 520 BTC for $34.9 million at an average price of $67,068 per Bitcoin, lifting total holdings to 847,363 BTC.
• Cumulative Bitcoin purchases now total $64.1 billion, implying an average acquisition cost of $75,651 per BTC.
• The company increased its U.S. dollar reserve by $300 million to $1.4 billion, with the balance including expected proceeds from unsettled ATM share sales.
• Strategy’s latest funding came from sales of its Class A common stock via its at-the-market (ATM) program, with $335.5 million raised during the reporting period.
• Strategy’s perpetual preferred stock (STRC), designed to trade around $100, slipped below $90 last week and remained volatile alongside MSTR shares.

New Bitcoin buy and updated treasury math

Strategy’s latest disclosed purchase appears as part of its ongoing Bitcoin accumulation program. In the 8‑K filing, the company states that it bought 520 BTC for $34.9 million during the period from June 15 through Sunday. The average price works out to $67,068 per Bitcoin.

That addition expands Strategy’s Bitcoin treasury to 847,363 BTC. Strategy also provided updated aggregate figures: its cumulative purchases total $64.1 billion, resulting in an average acquisition cost of $75,651 per Bitcoin. Those averages matter because they shape how investors think about the downside resilience of the company’s balance sheet and how efficiently Strategy is acquiring Bitcoin relative to prevailing market levels.

Beyond the immediate purchase, the filing underscores that Strategy continues to pair accumulation with liquidity management—an approach that can be as important as the Bitcoin number itself when corporate financing conditions or market volatility change.

Liquidity build: $300 million to the USD reserve

Alongside the Bitcoin purchase, Strategy said it added $300 million to its U.S. dollar reserve, raising the total to $1.4 billion. The company’s statement on X aligns with the 8‑K details, which specify that the USD reserve figure includes expected cash proceeds from its at-the-market (ATM) share sales that had not yet settled.

Strategy characterizes the reserve as a tool to support credit-related obligations, including dividend payments and debt coverage. In the 8‑K, the company said it plans to keep replenishing the USD reserve over time based on market conditions, with the objective of supporting the credit quality of its Digital Credit securities.

For holders and traders, this matters because reserve levels can influence how comfortable markets feel about Strategy’s ability to meet obligations during periods when equity funding becomes more expensive or when crypto prices swing sharply.

ATM share sales supply the cash for both goals

Strategy’s latest funding mechanics, as described in the filing, rely on its Class A common stock sales through an ATM equity program. The company raised $335.5 million during the reporting period, and the proceeds were split between the Bitcoin purchase and reserve build.

Of the $335.5 million, Strategy used $34.9 million to buy 520 BTC and allocated $300 million to the USD reserve. This structure keeps Strategy’s treasury growth closely tied to equity-market access, rather than depending solely on direct crypto-related financing.

Strategy’s financing decisions tend to draw attention precisely because it is one of the most active corporate buyers of Bitcoin and the largest listed corporate Bitcoin holder. As the firm has scaled its approach, it has effectively created a playbook for other Bitcoin treasury companies that want to combine crypto exposure with a tradable equity base.

STRC and MSTR volatility returns to focus

While Strategy’s filings provide the fundamentals, market pricing has also been part of the narrative. Ongoing volatility in Strategy’s share complex has remained in focus, particularly after the company’s perpetual preferred stock STRC—intended to trade near $100—fell below $90 last week.

Market data cited in the report shows MSTR shares down 3.46% to $112.53 at Thursday’s close, ahead of Friday’s market holiday, based on Yahoo Finance data. STRC declined 0.46% to $88.59 at Thursday’s close, and it traded at $90.59 during Monday’s premarket session.

Bitcoin advocate Samson Mow commented on X that STRC has a “self-repairing mechanism” that activates when the security trades below its $100 reference level. He said the process includes a stop in issuing new shares through the ATM program when the price falls under that threshold, effectively limiting new supply. Mow also argued that lower prices can increase the relative yield for buyers versus their entry price, which may encourage demand and help move STRC back toward $100.

The substance investors are likely watching is whether the structure’s incentives translate into sustained stabilization as market conditions evolve. If STRC pricing continues to deviate materially from the intended reference zone, traders may focus less on the theoretical mechanism and more on how quickly the market absorbs limited supply and whether equity-market conditions remain supportive.

Why this funding package matters to Bitcoin markets

Strategy’s combination of new Bitcoin purchases and reserve replenishment is more than an internal balance-sheet update. For the wider market, it signals ongoing corporate appetite for Bitcoin, even as equity prices and preferred-share pricing swing. At the same time, the company’s reliance on ATM equity sales highlights a key dependency: continued BTC accumulation is increasingly tied to how quickly and cheaply Strategy can access public markets.

That linkage becomes especially relevant when the company’s own share-linked instruments—like MSTR and STRC—show volatility. The latest disclosures and market moves together reinforce a central theme for corporate Bitcoin: treasury strategies can be durable, but their execution depends on liquidity and funding channels that may fluctuate with sentiment and broader market conditions.

Next, readers should watch whether Strategy’s reserve build translates into steadier market confidence around its Digital Credit-related objectives, and whether STRC’s “self-repairing” incentives prove effective as its trading price interacts with the $100 reference level.

Main Street Finance’s stablecoin msUSD has depegged to $0.27, sparked by a post addressing the “shutdown of [its] third-party proof-of-reserves dashboard.”

The following day, the firm behind the dashboard in question, Accountable, announced it was terminating its asset verification services with msUSD’s issuer.

In classic DeFi fashion, the fallout appears to have led to a bank run on Altura’s USDT vault, leading to the firm deciding to close down the vault.

At least $8.5 million was withdrawn ahead of the announcement and before a sell-off of the AVLT vault token led to an 11% depeg.

The weekend’s depegs come on the back of ongoing troubles for DeFi stablecoins apxUSD and sUSDat, which are backed by Strategy’s struggling STRC.

Read more: Saylor distances himself from STRC-backed DeFi after stablecoin wobble

Main Street Finance: ‘Institutional-grade yield’

Late on Saturday, Main Street Finance published a long post to X reassuring users that it “remains fully backed,” calling the loss of its dashboard a “reporting issue, not a solvency issue.”

By the time of the post, the price of msUSD had already collapsed. It sat at around $0.12 after losing its $1 peg around six hours previously but has since rebounded to around $0.27 from a low of $0.06 in the early hours of Sunday morning (UTC).

The advance reaction led some to believe that “insiders… got the memo that they should take the available liquidity to get out.”

Then, on Sunday, RWA accounting firm Accountable announced that, following Main Street Finance’s failure to provide adequate proof of reserves, it was terminating its contract with the firm.

Others questioned Accountable’s lack of prior action, given that doubts over Main Street’s transparency were publicly raised back in April.

Accountable’s post positions it as “neutral verification infrastructure,” however it also claims it “did not retain an ongoing, source-level view of [Main Street’s] reserves,” raising concerns over the reliability of its data on other clients.

Strive has purchased 759 Bitcoin for roughly $50 million, recording its largest weekly acquisition in months and surpassing Strategy’s latest BTC purchase.

According to a June 22 Form 8-K filed with the U.S. Securities and Exchange Commission, the Dallas-based Bitcoin treasury company acquired the coins between June 15 and June 21 at an average price of about $65,850 per Bitcoin, including fees and expenses. The transaction lifted Strive’s total holdings to 19,864 BTC.

At the reported purchase price, the acquisition was worth approximately $50 million. The buying spree represented a sharp increase from the company’s previous two weekly disclosures, which showed purchases of just 32 BTC and 73 BTC, respectively, totaling around $6.8 million.

While Strategy remains the world’s largest corporate Bitcoin holder, Strive accumulated more BTC during the latest reporting week. Strategy disclosed the purchase of 520 Bitcoin over a similar period, making this one of the few occasions when a smaller treasury company added more Bitcoin than its larger rival.

Strive has accelerated Bitcoin accumulation again

Fresh SEC filings also showed that Strive’s cash and cash equivalents increased from $141.4 million to $144.5 million during the reporting period. At the same time, the company’s Class A common stock count expanded by roughly 1.9 million shares to 71.8 million, indicating continued capital raising activity through its at-the-market equity program.

Elsewhere on the balance sheet, Strive maintained its position of 505,000 shares in Strategy’s Variable Rate Series A Perpetual Stretch Preferred Stock, known as STRC. According to the filing, the fair value of those holdings edged lower to approximately $44.7 million.

The latest purchase extends a rapid expansion that began after Strive entered the public Bitcoin treasury sector through its January 2026 merger with Semler Scientific. The transaction added 5,048 BTC to the company’s balance sheet at closing and provided the foundation for its current accumulation strategy.

Since then, Strive has steadily increased its Bitcoin reserves. The company crossed the 15,000 BTC threshold in early May and later disclosed a roughly $185 million deployment in early June that added about 2,500 Bitcoin in a single week, one of the largest acquisitions since becoming a public company.

SATA funding model continues to support purchases

A significant portion of Strive’s buying activity has been funded through its Variable Rate Series A Perpetual Preferred Stock program, known as SATA. The preferred shares currently offer a Bitcoin-linked dividend structured at an annualized rate of 13%, calculated daily.

According to company disclosures, capital raised through SATA and other at-the-market programs is directed toward additional Bitcoin purchases. Strive Management has previously described Bitcoin as the benchmark against which it evaluates capital allocation decisions rather than simply a reserve asset held on the balance sheet.

Based on Bitcoin (BTC) prices near $64,000, Strive’s treasury of 19,864 BTC is currently valued at roughly $1.27 billion. Company filings indicate that its average acquisition cost remains above prevailing market prices, a position it shares with Strategy, which holds 847,363 BTC and remains the largest corporate Bitcoin holder globally.

With a previously announced $4.2 billion capital deployment plan still in place, recent filings suggest Strive continues to expand its Bitcoin position as the second half of 2026 approaches.